Cellular Dynamics - Top 15 Biotech VC Deals of 2010

Company: Cellular Dynamics International
Based: Madison, WI
Amount: $40.6M

Investors: Tactics II Stem Cell Ventures, Sam Zell's Equity Group Investments and Sixth Floor Investors

Scoop: A 2008 Fierce 15 member, Cellular Dynamics added $40.6 million in Series B financing to grow its stem cell production. The company is the world's highest volume manufacturer of human heart cells and plans to use the added funds to enter other markets.

Cellular Dynamics - Top 15 Biotech VC Deals of 2010
Read more on

Suggested Articles

Acceleron’s sotatercept outdid placebo at reducing pulmonary vascular resistance in patients with pulmonary arterial hypertension.

China’s Biotheus picked up the rights to Tilt Biotherapeutics’ lead oncolytic virus program in greater China.

A Cedars-Sinai team used stem cells to uncover a key mechanism of young onset Parkinson's, as well as a potential remedy—an existing skin treatment.